Michal Izrael

This inventor holds 5 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Yeda Research and Develpment & Co. Ltd, Kadimastem Ltd., The Weizmann Institute of Science. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michal Izrael. Retrieved from https://idiyas.com/inventor/michal-izrael

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 7(Granted Patents)

Location History:

Rehovot, IL (2016)
Rechovot, IL (2014 - 2022)

Company Filing History:

3 out of 1,168

Yeda Research and Develpment & Co. Ltd

The Weizmann Institute of Science

patents

Years Active: 2014-2022

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11406670 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2022-08-09),

2. 10258651 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2019-04-16),

3. 9631175 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2017-04-25),

4. 9404087 - Insulin producing cells derived from pluripotent stem cells (2016-08-02),

5. 8809052 - Methods of generating mature oligodendrocytes (2014-08-19),

Title: Michal Izrael: Innovator in Neural Cell Generation

Introduction

Michal Izrael is a prominent inventor based in Rechovot, Israel. He has made significant contributions to the field of neuroscience, particularly in the generation of glial and neuronal cells. With a total of 5 patents, his work has the potential to impact the treatment of various medical conditions affecting the central nervous system (CNS).

Latest Patents

One of Michal Izrael's latest patents focuses on methods of generating glial and neuronal cells for the treatment of medical conditions of the CNS. This innovative method involves growing human stem cells under specific conditions that promote their differentiation into neural and glial cells. The process includes the presence of retinoic acid and an agent that down-regulates Bone Morphogenic Protein activity. This advancement could pave the way for new therapeutic approaches in neuroscience.

Career Highlights

Throughout his career, Michal has worked with notable organizations, including Yeda Research and Development Co. Ltd. and Kadimastem Ltd. His experience in these companies has allowed him to refine his research and contribute to groundbreaking advancements in cell generation.

Collaborations

Michal has collaborated with esteemed colleagues such as Michel Revel and Judith Chebath. These partnerships have further enriched his research and innovation in the field of neuroscience.

Conclusion

In summary, Michal Izrael is a dedicated inventor whose work in generating glial and neuronal cells holds promise for the future of CNS treatments. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.